(Q44596044)

4 December 2017

title

Tigecycline as a therapeutic option in Stenotrophomonas maltophilia infections (English)

1 reference

Stenotrophomonas maltophilia

4 December 2017

main subject

1 reference

Yasemin Tezer Tekçe

1

1 reference

4 December 2017

Ayşe Erbay

series ordinal

2

1 reference

4 December 2017

Hatice Cabadak

series ordinal

3

1 reference

4 December 2017

Süha Sen

series ordinal

4

1 reference

4 December 2017

publication date

1 June 2012

1 reference

4 December 2017

published in

Journal of Chemotherapy

1 reference

4 December 2017

volume

24

1 reference

4 December 2017

issue

3

1 reference

4 December 2017

page(s)

150-154

1 reference

Stenotrophomonas maltophilia: an emerging opportunist human pathogen

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1179%2F1120009X12Z.00000000022

Therapeutic options for Stenotrophomonas maltophilia infections beyond co-trimoxazole: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1120009X12Z.00000000022

Antimicrobial susceptibilities of a worldwide collection of Stenotrophomonas maltophilia isolates tested against tigecycline and agents commonly used for S. maltophilia infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1120009X12Z.00000000022

Stenotrophomonas maltophilia resistant to trimethoprim-sulfamethoxazole: an increasing problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1120009X12Z.00000000022

Tigecycline in combination with other antimicrobials: a review of in vitro, animal and case report studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1120009X12Z.00000000022

Antimicrobial therapy for Stenotrophomonas maltophilia infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1120009X12Z.00000000022

APACHE II: a severity of disease classification system

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1120009X12Z.00000000022

Comparison of different antimicrobial susceptibility testing methods for Stenotrophomonas maltophilia and results of synergy testing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1120009X12Z.00000000022

Treatment of Recurrent Stenotrophomonas maltophilia Ventilator-Associated Pneumonia with Doxycycline and Aerosolized Colistin

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1120009X12Z.00000000022

Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (199

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1120009X12Z.00000000022

Contemporary in vitro spectrum of activity summary for antimicrobial agents tested against 18569 strains non-fermentative Gram-negative bacilli isolated in the SENTRY Antimicrobial Surveillance Program (1997-2001).

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1120009X12Z.00000000022

Comparative in vitro activities of tigecycline (GAR-936) and other antimicrobial agents against Stenotrophomonas maltophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1120009X12Z.00000000022

Antimicrobial susceptibility of uncommonly isolated non-enteric Gram-negative bacilli

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1120009X12Z.00000000022

Antimicrobial susceptibility profile of contemporary clinical strains of Stenotrophomonas maltophilia isolates: can moxifloxacin activity be predicted by levofloxacin MIC results?

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1120009X12Z.00000000022

Activity of levofloxacin and ciprofloxacin on biofilms and planktonic cells of Stenotrophomonas maltophilia isolates from patients with device-associated infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1120009X12Z.00000000022

Levofloxacin and ciprofloxacin in vitro activities against 4,003 clinical bacterial isolates collected in 24 Italian laboratories

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1120009X12Z.00000000022

Antimicrobial activity of tigecycline tested against organisms causing community-acquired respiratory tract infection and nosocomial pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1120009X12Z.00000000022

Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1120009X12Z.00000000022

Successful treatment of Stenotrophomonas maltophilia soft tissue infection with tigecycline: a case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1120009X12Z.00000000022

Tigecycline for treatment of nosocomial-acquired pneumonia possibly caused by multi-drug resistant strains of Stenotrophomonas maltophilia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1120009X12Z.00000000022

Pharmacokinetics of Tigecycline after Single and Multiple Doses in Healthy Subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1120009X12Z.00000000022

In vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii and Stenotrophomonas maltophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1120009X12Z.00000000022

10.1179/1120009X12Z.00000000022

21 January 2018

Identifiers

DOI

1 reference

4 December 2017

1 reference